India will have a new agency, modelled on the US Food and Drug Administration, in place by the end of 2006, according to local media reports. The go-ahead from the Indian government's cabinet is expected soon. The new body - the National Drug Agency - would replace the exist-ing Central Drugs Standard Control Organization and local state-level drug regulation agencies.
As a result, the functions of approving new drugs; issuing marketing and import licenses for new drugs; manu-facturing licenses; inspection of production facilities; and trade licensing, will all be dealt with by the same authority.
The NDA would be governed by an advisory board, assem-bling representatives from the Ministry of Health, the Ministry of Chemicals and the Department of Biotech-nology, together with patient and consumer groups and non-governmental organizations.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze